Serum concentration of chromogranin A at admission: An early biomarker of severity in critically ill patients

References

• Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000; 26(Suppl 1)S64–74
   PubMed Web of Science ®Google Scholar
• Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164: 396–402
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270: 2957–63
   PubMed Web of Science ®Google Scholar
• Banks P, Helle KB. The release of proteins from the stimulated adrenal medulla. Biochem J. 1965; 97: 40C–41C
   PubMed Web of Science ®Google Scholar
• Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med. 2003; 348: 1134–49
   PubMed Web of Science ®Google Scholar
• Aardal S, Helle KB. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pept. 1992; 41: 9–18
   PubMedGoogle Scholar
• Glattard E, Angelone T, Strub JM, Corti A, Aunis D, Tota B, et al. Characterization of natural vasostatin-containing peptides in rat heart. FEBS J. 2006; 273: 3311–21
   Google Scholar
• Cryer PE, Worstman J, Shah SD, Nowak RM, Deftos LJ. Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol. 1991; 260 Pt1: E243–6
   Google Scholar
• Rozansky DJ, Wu H, Tang K, Parmer RJ, O'Connor DT. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element. J Clin Invest. 1994; 94: 2357–68
   PubMed Web of Science ®Google Scholar
• Giusti M, Sidoti M, Augeri M, Rabitti C, Minuto F. Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. Eur J Endocrinol. 2004; 150: 299–303
   PubMedGoogle Scholar
• Antonelli M, Levy M, Andrews PJ, Chatre J, Hudson LD, Manthous C, et al. Hemodynamic monitoring in shock and implication for management. Intensive Care Med. 2007; 33: 575–90
   PubMed Web of Science ®Google Scholar
• Ziegler MG, Kennedy B, Morrissey E, O'Connor DT. Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure. Kidney Int. 1990; 37: 1357–62
   PubMed Web of Science ®Google Scholar
• Ceconi C, Ferrari R, Bachetti, Opasich C, Volterrani M, Colombo B. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J. 1990; 23: 967–74
   Google Scholar
• Estensen ME, Hognestad A, Syversen U, Squire I, Ng L, Kjekshus J, et al. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. Am Heart J. 2006; 152: 927.e1–6
   Google Scholar
• Tasiemski A, Hammad H, Vandenbulcke F, Breton C, Bilfinger TJ, Pestel J, et al. Presence of chromogranin-derived antimicrobial peptides in plasma during coronary artery-bypass surgery and evidence of an immune origin of these peptides. Blood. 2002; 100: 553–9
   Google Scholar
• Lominadze G, Powell DW, Luerman GC, Link AJ, Ward RA, Mc Leisch KR. Proteomic analysis of human neutrophil granules. Mol Cell Proteomics. 2005; 4: 1503–21
   PubMed Web of Science ®Google Scholar
• Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 2005; 18: 41–71
   PubMed Web of Science ®Google Scholar
• Ciesielski-Treska J, Ulrich G, Chasserot-Golaz S, Zwiller J, Revel MO, Aunis D, et al. Mechanisms underlying neuronal death induced by chromogranin A-activated microglia. J Biol Chem. 2001; 276: 13113–20
   Google Scholar
• Kingham PJ, Pocock J. Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome C release. J Neurochem. 2000; 74: 1452–62
   Google Scholar
• Adrie C, Bachelet M, Vayssier-Taussat M, Russo-Marie F, Bouchaert I, Adib-Conquy M, et al. Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med. 2001; 164: 389–95
   PubMed Web of Science ®Google Scholar